Functional analyses of pathogenicity determinants of SARS-Coronavirus-2 delta variant
Victoria Ansalem, Anil Kumar |
University of Saskatchewan | Project Grant | $96,270
CIHR Saskatchewan 2021
Read More
SARS-CoV-2 virus infection in vaccinated vulnerable populations and the potential for variant emergence
Kelvin, Alyson A |
University of Saskatchewan | Operating Grant | $499,900
CIHR Saskatchewan 2021
Read More
COVID-19 Variant Supplement – Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
Falzarano, Darryl |
University of Saskatchewan | Operating Grant | $50,000
CIHR Saskatchewan 2021
Read More
COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.
Wilson, Joyce A |
University of Saskatchewan | Operating Grant | $50,000
CIHR Saskatchewan 2021
Read More
COVID-19 Variant Supplement – BLT-Lung mice for the rapid evaluation of COVID‑19 therapeutics
Lavender, Kerry J |
University of Saskatchewan | Operating Grant | $50,000
CIHR Saskatchewan 2021
Read More